Litcius/Paper detail

Homogeneous Polyporus Polysaccharide Inhibit Bladder Cancer by Resetting Tumor-Associated Macrophages Toward M1 Through NF-κB/NLRP3 Signaling

Chunping Liu, Dongyue He, Shihui Zhang, Huiqi Chen, Jie Zhao, Xiong Li, Xing Zeng

2022Frontiers in Immunology24 citationsDOIOpen Access PDF

Abstract

Bladder cancer(BC)is one of the most common urinary system tumors, which characterized by a high incidence. Polyporus polysaccharide is the main active component of polyporus, which is clinically used in the treatment of bladder cancer, but the mechanism is not clear. In previous study, we isolated homogeneous polyporus polysaccharide(HPP) with high purity from polyporus. The goal of this study was to assess the polarization of macrophages induced by HPP in the bladder tumor microenvironment and explored its anti-bladder cancer mechanism through BBN bladder cancer rat model and Tumor associated macrophages(TAM). The results suggested that HPP regulates TAM polarization to improve the tumor inflammatory microenvironment, possibly through the NF-κB/NLRP3 signaling pathway. Our results suggested that HPP may be a potential therapeutic agent for bladder tumors.

Topics & Concepts

Bladder cancerCancer researchPolyporusTumor microenvironmentCancerPolysaccharideHomogeneousMedicineNF-κBChemistryImmunologyTumor cellsInflammationInternal medicineBiochemistryThermodynamicsPhysicsImmune cells in cancerBladder and Urothelial Cancer TreatmentsInflammasome and immune disorders
Homogeneous Polyporus Polysaccharide Inhibit Bladder Cancer by Resetting Tumor-Associated Macrophages Toward M1 Through NF-κB/NLRP3 Signaling | Litcius